“…The genetic susceptibility of these diseases is thought to be polygenic. It has been reported that major histocompatibility complex (MHC) gene [3,4], cytotoxic T lymphocyte antigen-4 (CTLA-4) gene [4][5][6], thyrotropin receptor (TSHR) gene [7], PTPN22 gene [8], CD40 gene [9,10], interferon-γ (IFN-γ) gene [11], tumor necrosis factor-α (TNF-α) gene [12,13] and interleukin-13 (IL-13) gene [14] polymorphisms are associated with GD and their interactions may influence disease phenotype and severity [3]. However, their contribution to susceptibility to GO awaits confirmation.…”